{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:25:14Z","timestamp":1790889914213,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"DOI":"10.1007\/s11882-025-01246-1","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T02:49:41Z","timestamp":1767926981000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Chronic Rhinosinusitis Optimisation of Nasal Outcomes and Scores (CHRONOS): An Italian Delphi Consensus on Long-Term Management with Biologics"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5761-7018","authenticated-orcid":false,"given":"Eugenio","family":"De Corso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank Rikki Mauritz","family":"Canevari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7383-1487","authenticated-orcid":false,"given":"Marco","family":"Caminati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Pipolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Heffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Lazzeroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Seccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Garzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Ottaviano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Cantone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Pagella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Gramellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignazio","family":"La Mantia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Moffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Pasquini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Loperfido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Torretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Cecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Luca","family":"Fadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giandomenico","family":"Maggiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Pelucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Iannuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Lucidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Macchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Padoan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Patella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Dan\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Montuori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Corb\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio Walter","family":"Canonica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianenrico","family":"Senna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"issue":"1","key":"1246_CR1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/all.13984","volume":"75","author":"C Bachert","year":"2020","unstructured":"Bachert C, Hellings PW, Mullol J, Hamilos DL, Gevaert P, Naclerio RM, et al. Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposis. Allergy. 2020;75(1):148\u201357. https:\/\/doi.org\/10.1111\/all.13984.","journal-title":"Allergy"},{"issue":"3","key":"1246_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4193\/Rhin19.468","volume":"58","author":"ES Lourijsen","year":"2020","unstructured":"Lourijsen ES, Fokkens WJ, Reitsma S. Direct and indirect costs of adult patients with chronic rhinosinusitis with nasal polyps. Rhinology. 2020;58(3):213\u20137. https:\/\/doi.org\/10.4193\/Rhin19.468.","journal-title":"Rhinology"},{"issue":"3","key":"1246_CR3","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4193\/Rhin22.489","volume":"61","author":"WJ Fokkens","year":"2023","unstructured":"Fokkens WJ, Viskens AS, Backer V, Conti D, De Corso E, Gevaert P, et al. EPOS\/EUFOREA update on indication and evaluation of biologics in chronic rhinosinusitis with nasal polyps 2023. Rhinology. 2023;61(3):194\u2013202. https:\/\/doi.org\/10.4193\/Rhin22.489.","journal-title":"Rhinology"},{"issue":"Suppl S29","key":"1246_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4193\/Rhin20.600","volume":"58","author":"WJ Fokkens","year":"2020","unstructured":"Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58(Suppl S29):1\u2013464. https:\/\/doi.org\/10.4193\/Rhin20.600.","journal-title":"Rhinology"},{"issue":"5","key":"1246_CR5","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1111\/all.16499","volume":"80","author":"S Cai","year":"2025","unstructured":"Cai S, Xu S, Zhao Y, Zhang L. Efficacy and safety of biologics for chronic rhinosinusitis with nasal polyps: a meta-analysis of real-world evidence. Allergy. 2025;80(5):1256\u201370. https:\/\/doi.org\/10.1111\/all.16499.","journal-title":"Allergy"},{"issue":"1","key":"1246_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14639\/0392-100X-N1614","volume":"42","author":"E De Corso","year":"2022","unstructured":"De Corso E, Bellocchi G, De Benedetto M, Lombardo N, Macchi A, Malvezzi L, et al. Biologics for severe uncontrolled chronic rhinosinusitis with nasal polyps: a change management approach. Consensus of the Joint Committee of Italian Society of Otorhinolaryngology on biologics in rhinology. Acta Otorhinolaryngol Ital. 2022;42(1):1\u201316. https:\/\/doi.org\/10.14639\/0392-100X-N1614.","journal-title":"Acta Otorhinolaryngol Ital"},{"issue":"10","key":"1246_CR7","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1111\/all.15772","volume":"78","author":"E De Corso","year":"2023","unstructured":"De Corso E, Pasquini E, Trimarchi M, La Mantia I, Pagella F, Ottaviano G, et al. Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): a multicentric observational phase IV real-life study (DUPIREAL). Allergy. 2023;78(10):2669\u201383. https:\/\/doi.org\/10.1111\/all.15772.","journal-title":"Allergy"},{"issue":"10209","key":"1246_CR8","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","volume":"394","author":"C Bachert","year":"2019","unstructured":"Bachert C, Han JK, Desrosiers M, Hellings PW, Amin N, Lee SE, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet. 2019;394(10209):1638\u201350. https:\/\/doi.org\/10.1016\/S0140-6736(19)31881-1.","journal-title":"Lancet"},{"issue":"12","key":"1246_CR9","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/S2213-2600(25)00287-5","volume":"13","author":"E De Corso","year":"2025","unstructured":"De Corso E, Canonica GW, Heffler E, Springer M, Grzegorzek T, Viana M, et al. Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST): a multicentre, randomised, double-blind, head-to-head phase 4 trial. Lancet Respir Med. 2025;13(12):1067\u201377. https:\/\/doi.org\/10.1016\/S2213-2600(25)00287-5.","journal-title":"Lancet Respir Med"},{"key":"1246_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/all.70032","author":"E De Corso","year":"2025","unstructured":"De Corso E, Montuori C, Pipolo C, La Mantia I, Pasquini E, Ghidini A, et al. Two-year turning point with dupilumab in CRSwNP: Control, remission, and tapering dosage. Allergy. 2025. https:\/\/doi.org\/10.1111\/all.70032.","journal-title":"Allergy"},{"issue":"10","key":"1246_CR11","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/S2213-2600(21)00097-7","volume":"9","author":"JK Han","year":"2021","unstructured":"Han JK, Bachert C, Fokkens W, Desrosiers M, Wagenmann M, Lee SE, et al. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med. 2021;9(10):1141\u201353. https:\/\/doi.org\/10.1016\/S2213-2600(21)00097-7.","journal-title":"Lancet Respir Med"},{"issue":"3","key":"1246_CR12","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jaci.2020.05.032","volume":"146","author":"P Gevaert","year":"2020","unstructured":"Gevaert P, Omachi TA, Corren J, Mullol J, Han J, Lee SE, et al. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials. J Allergy Clin Immunol. 2020;146(3):595\u2013605. https:\/\/doi.org\/10.1016\/j.jaci.2020.05.032.","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"1246_CR13","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1056\/NEJMoa2414482","volume":"392","author":"BJ Lipworth","year":"2025","unstructured":"Lipworth BJ, Han JK, Desrosiers M, Hopkins C, Lee SE, Mullol J, et al. Tezepelumab in adults with severe chronic rhinosinusitis with nasal polyps. N Engl J Med. 2025;392(12):1178\u201388.","journal-title":"N Engl J Med"},{"issue":"4","key":"1246_CR14","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.jaci.2021.08.030","volume":"149","author":"C Bachert","year":"2022","unstructured":"Bachert C, Han JK, Desrosiers MY, Gevaert P, Heffler E, Hopkins C, et al. Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: a randomized, placebo-controlled trial. J Allergy Clin Immunol. 2022;149(4):1309-1317.e12. https:\/\/doi.org\/10.1016\/j.jaci.2021.08.030.","journal-title":"J Allergy Clin Immunol"},{"issue":"10482","key":"1246_CR15","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0140-6736(25)00197-7","volume":"405","author":"P Gevaert","year":"2025","unstructured":"Gevaert P, Desrosiers M, Cornet M, Mullol J, De Corso E, Keles Turel N, et al. Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials. Lancet. 2025;405(10482):911\u201326. https:\/\/doi.org\/10.1016\/S0140-6736(25)00197-7.","journal-title":"Lancet"},{"issue":"3","key":"1246_CR16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s11882-024-01135-z","volume":"24","author":"E De Corso","year":"2024","unstructured":"De Corso E, Pipolo C, Caminati M, Cantone E, Seccia V, Cecchi L, et al. Multidisciplinary decision-making-ITAlian consensus after two years of real practice on the management of severe uncontrolled CRSwNP by biologics (ITACA study). Curr Allergy Asthma Rep. 2024;24(3):143\u201354. https:\/\/doi.org\/10.1007\/s11882-024-01135-z.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"3","key":"1246_CR17","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4193\/Rhin23.415","volume":"62","author":"WJ Fokkens","year":"2024","unstructured":"Fokkens WJ, De Corso E, Backer V, Bernal-Sprekelsen M, Bjermer L, von Buchwald C, et al. EPOS2020\/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNP. Rhinology. 2024;62(3):287\u201398. https:\/\/doi.org\/10.4193\/Rhin23.415.","journal-title":"Rhinology"},{"issue":"4","key":"1246_CR18","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1111\/all.16496","volume":"80","author":"JJ Otten","year":"2025","unstructured":"Otten JJ, Elzinga HE, van der Lans RJL, Fokkens WJ, Reitsma S. Almost half of the dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps achieve remission in one year. Allergy. 2025;80(4):1166\u20138. https:\/\/doi.org\/10.1111\/all.16496.","journal-title":"Allergy"},{"issue":"10","key":"1246_CR19","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1111\/all.15796","volume":"78","author":"RJL van der Lans","year":"2023","unstructured":"van der Lans RJL, Otten JJ, Adriaensen GFJPM, Hoven DR, Benoist LB, Fokkens WJ, et al. Two-year results of tapered dupilumab for CRSwNP demonstrates enduring efficacy established in the first 6 months. Allergy. 2023;78(10):2684\u201397.","journal-title":"Allergy"},{"issue":"11","key":"1246_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14113654","volume":"14","author":"T Tajiri","year":"2025","unstructured":"Tajiri T, Suzuki M, Nishiyama H, Ozawa Y, Amakusa Y, Suzuki T, et al. Dupilumab-induced remission in chronic rhinosinusitis with nasal polyps and comorbid asthma: a 24-month study. J Clin Med. 2025;14(11):3654. https:\/\/doi.org\/10.3390\/jcm14113654.","journal-title":"J Clin Med"},{"issue":"2","key":"1246_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2024.101024","volume":"18","author":"M Al-Ahmad","year":"2025","unstructured":"Al-Ahmad M, Ali A, Talat W, Dawood HA, Imam O. Long-term effects of dupilumab on chronic rhinosinusitis with nasal polyps: a step towards clinical remission. World Allergy Organ J. 2025;18(2):101024. https:\/\/doi.org\/10.1016\/j.waojou.2024.101024.","journal-title":"World Allergy Organ J"},{"issue":"2","key":"1246_CR22","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4193\/Rhin24.457","volume":"63","author":"PW Hellings","year":"2025","unstructured":"Hellings PW, De Corso E, Backer V, Bernal-Sprekelsen M, Chan Y, Conti DM, et al. Remission in chronic rhinosinusitis with nasal polyps (CRSwNP). Rhinology. 2025;63(2):239\u201341. https:\/\/doi.org\/10.4193\/Rhin24.457.","journal-title":"Rhinology"},{"issue":"34","key":"1246_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4193\/Rhin24.090","volume":"62","author":"AR Sedaghat","year":"2024","unstructured":"Sedaghat AR, Campbell RG, Douglas RG, Fokkens WJ, Hamizan AW, Korban ZR, et al. Outcome measures for chronic rhinosinusitis with nasal polyps. Rhinology. 2024;62(34):1\u201337. https:\/\/doi.org\/10.4193\/Rhin24.090.","journal-title":"Rhinology"},{"issue":"25","key":"1246_CR24","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1200\/JCO.2012.42.0489","volume":"30","author":"DA Loblaw","year":"2012","unstructured":"Loblaw DA, Prestrud AA, Somerfield MR, Oliver TK, Brouwers MC, Nam RK, et al. American society of clinical oncology clinical practice guidelines: formal systematic review-based consensus methodology. J Clin Oncol. 2012;30(25):3136\u201340. https:\/\/doi.org\/10.1200\/JCO.2012.42.0489.","journal-title":"J Clin Oncol"},{"issue":"10","key":"1246_CR25","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1097\/ACM.0000000000001812","volume":"92","author":"S Humphrey-Murto","year":"2017","unstructured":"Humphrey-Murto S, Varpio L, Wood TJ, Gonsalves C, Ufholz LA, Mascioli K, et al. The use of the Delphi and other consensus group methods in medical education research: a review. Acad Med. 2017;92(10):1491\u20138. https:\/\/doi.org\/10.1097\/ACM.0000000000001812.","journal-title":"Acad Med"},{"issue":"1","key":"1246_CR26","doi-asserted-by":"publisher","first-page":"e1004326","DOI":"10.1371\/journal.pmed.1004326","volume":"21","author":"WT Gattrell","year":"2024","unstructured":"Gattrell WT, Logullo P, van Zuuren EJ, Price A, Hughes EL, Blazey P, et al. Accord (accurate consensus reporting document): a reporting guideline for consensus methods in biomedicine developed via a modified Delphi. PLoS Med. 2024;21(1):e1004326. https:\/\/doi.org\/10.1371\/journal.pmed.1004326.","journal-title":"PLoS Med"},{"issue":"11","key":"1246_CR27","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1111\/all.16263","volume":"79","author":"P Huber","year":"2024","unstructured":"Huber P, F\u00f6rster-Ruhrmann U, Olze H, Becker S, B\u00e4rhold F, Cuevas M, et al. Real-world data show sustained therapeutic effects of dupilumab in chronic rhinosinusitis with nasal polyps (CRSwNP) over 3 years. Allergy. 2024;79(11):3108\u201317. https:\/\/doi.org\/10.1111\/all.16263.","journal-title":"Allergy"},{"issue":"4","key":"1246_CR28","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/ard.2009.123919","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010;69(4):631\u20137. https:\/\/doi.org\/10.1136\/ard.2009.123919.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"1246_CR29","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s11882-024-01154-w","volume":"24","author":"C Rodriguez-Van Strahlen","year":"2024","unstructured":"Rodriguez-Van Strahlen C, Arancibia C, Calvo-Henriquez C, Mullol J, Alobid I. Systematic review of long term sinonasal outcomes in CRSwNP after endoscopic sinus surgery: a call for unified and standardized criteria and terms. Curr Allergy Asthma Rep. 2024;24(8):443\u201356. https:\/\/doi.org\/10.1007\/s11882-024-01154-w.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"1","key":"1246_CR30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.12932\/AP-310321-1102","volume":"42","author":"E Penttil\u00e4","year":"2024","unstructured":"Penttil\u00e4 E, Sillanp\u00e4\u00e4 S, Vento SI, Myller J, Koskinen A, Hammar\u00e9n-Malmi S, et al. Eosinophilia, asthma, N-ERD and the use of oral corticosteroids predict uncontrolled chronic rhinosinusitis with nasal polyps after surgery. Asian Pac J Allergy Immunol. 2024;42(1):50\u201360. https:\/\/doi.org\/10.12932\/AP-310321-1102.","journal-title":"Asian Pac J Allergy Immunol"},{"key":"1246_CR31","doi-asserted-by":"publisher","unstructured":"Xu S, Li Y, Pan X, Zhao Y, Wu D. Different response criteria and response rates for biologic therapy in patients with chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis. Ear Nose Throat J. 2025:1455613251362034. https:\/\/doi.org\/10.1177\/01455613251362034.","DOI":"10.1177\/01455613251362034"},{"issue":"8","key":"1246_CR32","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1016\/j.jaip.2019.05.009","volume":"7","author":"WW Stevens","year":"2019","unstructured":"Stevens WW, Peters AT, Tan BK, Klingler AI, Poposki JA, Hulse KE, et al. Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis. J Allergy Clin Immunol Pract. 2019;7(8):2812-2820.e3.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"1246_CR33","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/17476348.2024.2365841","volume":"18","author":"A Portacci","year":"2024","unstructured":"Portacci A, Dragonieri S, Carpagnano GE. Type-2 severe asthma comorbidities in the era of biologics: time to rethink clinical response? Expert Rev Respir Med. 2024;18(5):249\u201353. https:\/\/doi.org\/10.1080\/17476348.2024.2365841.","journal-title":"Expert Rev Respir Med"},{"issue":"4","key":"1246_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjorl.2025.101633","volume":"91","author":"H Chen","year":"2025","unstructured":"Chen H, Wang L, Zhang J, Yan X, Yu L, Jiang Y. Long-term efficacy and safety of different biologics in treatment of chronic rhinosinusitis with nasal polyps: a network meta-analysis. Braz J Otorhinolaryngol. 2025;91(4):101633. https:\/\/doi.org\/10.1016\/j.bjorl.2025.101633.","journal-title":"Braz J Otorhinolaryngol"},{"issue":"5","key":"1246_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2025.104705","volume":"46","author":"X Fang","year":"2025","unstructured":"Fang X, Zhou T, Ye F. Analysis of adverse reaction characteristics of four biologics for the treatment of chronic sinusitis with nasal polyps: a descriptive analysis from WHO-VigiAccess. Am J Otolaryngol. 2025;46(5):104705. https:\/\/doi.org\/10.1016\/j.amjoto.2025.104705.","journal-title":"Am J Otolaryngol"},{"issue":"1\u20132","key":"1246_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/14712598.2024.2304556","volume":"24","author":"M Caminati","year":"2024","unstructured":"Caminati M, Micheletto C, Norelli F, Olivieri B, Ottaviano G, Padoan R, et al. Safety of dupilumab in T2 airways conditions: focus on eosinophilia across trials and real-life evidence. Expert Opin Biol Ther. 2024;24(1\u20132):15\u201323. https:\/\/doi.org\/10.1080\/14712598.2024.2304556.","journal-title":"Expert Opin Biol Ther"},{"issue":"6","key":"1246_CR37","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.jaip.2025.01.040","volume":"13","author":"M Caminati","year":"2025","unstructured":"Caminati M, Maule M, Bagnasco D, Begh\u00e8 B, Braido F, Brussino L, et al. Profiling blood hypereosinophilia in patients on dupilumab treatment for respiratory conditions: a real-life snapshot. J Allergy Clin Immunol Pract. 2025;13(6):1367-1374.e4. https:\/\/doi.org\/10.1016\/j.jaip.2025.01.040.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"1246_CR38","doi-asserted-by":"publisher","first-page":"386","DOI":"10.4193\/Rhin24.528","volume":"63","author":"M Lazzeroni","year":"2025","unstructured":"Lazzeroni M, Kemp P, Fokkens WJ, Reitsma S. Eosinophilic complications during dupilumab therapy for type 2 diseases: a systematic review. Rhinology. 2025;63(4):386\u201396. https:\/\/doi.org\/10.4193\/Rhin24.528.","journal-title":"Rhinology"},{"issue":"5","key":"1246_CR39","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1007\/s00405-023-08417-8","volume":"281","author":"E De Corso","year":"2024","unstructured":"De Corso E, Montuori C, Baroni S, Mastrapasqua RF, Porru DP, D\u2019Auria LM, et al. Temporal trends of blood eosinophilia in severe uncontrolled CRSwNP treated with dupilumab: a real-life study. Eur Arch Otorhinolaryngol. 2024;281(5):2429\u201340. https:\/\/doi.org\/10.1007\/s00405-023-08417-8.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"6","key":"1246_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5604\/01.3001.0054.8684","volume":"78","author":"P Kuna","year":"2024","unstructured":"Kuna P, Jassem E, Wiatr E, Bazan-Socha S, Kupry\u015b-Lipi\u0144ska I. Hyper eosinophilic diseases - diagnosis and therapeutic approach - practical position of the Polish working group. Otolaryngol Pol. 2024;78(6):1\u201313. https:\/\/doi.org\/10.5604\/01.3001.0054.8684.","journal-title":"Otolaryngol Pol"},{"key":"1246_CR41","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin25.266","author":"E De Corso","year":"2025","unstructured":"De Corso E, et al. Clinical management of dupilumab-induced blood eosinophilia in CRSwNP: a practical algorithm. Rhinology. 2025. https:\/\/doi.org\/10.4193\/Rhin25.266.","journal-title":"Rhinology"},{"issue":"4","key":"1246_CR42","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/1756-185X.12823","volume":"20","author":"IJ Hyndman","year":"2017","unstructured":"Hyndman IJ. Rheumatoid arthritis: past, present and future approaches to treating the disease. Int J Rheum Dis. 2017;20(4):417\u20139. https:\/\/doi.org\/10.1111\/1756-185X.12823.","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"1246_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2015-207524","volume":"75","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P, et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis. 2016;75(1):3\u201315. https:\/\/doi.org\/10.1136\/annrheumdis-2015-207524.","journal-title":"Ann Rheum Dis"},{"issue":"10335","key":"1246_CR44","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/S0140-6736(22)00331-2","volume":"399","author":"M Lommatzsch","year":"2022","unstructured":"Lommatzsch M, Brusselle GG, Canonica GW, Jackson DJ, Nair P, Buhl R, et al. Disease-modifying anti-asthmatic drugs. Lancet. 2022;399(10335):1664\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(22)00331-2.","journal-title":"Lancet"},{"issue":"6","key":"1246_CR45","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.pcrj.2006.09.002","volume":"15","author":"G Crompton","year":"2006","unstructured":"Crompton G. A brief history of inhaled asthma therapy over the last fifty years. Prim Care Respir J. 2006;15(6):326\u201331. https:\/\/doi.org\/10.1016\/j.pcrj.2006.09.002.","journal-title":"Prim Care Respir J"},{"issue":"3","key":"1246_CR46","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.jaci.2019.12.006","volume":"145","author":"A Menzies-Gow","year":"2020","unstructured":"Menzies-Gow A, Bafadhel M, Busse WW, Casale TB, Kocks JWH, Pavord ID, et al. An expert consensus framework for asthma remission as a treatment goal. J Allergy Clin Immunol. 2020;145(3):757\u201365. https:\/\/doi.org\/10.1016\/j.jaci.2019.12.006.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1246_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4193\/Rhino12.000","volume":"50","author":"WJ Fokkens","year":"2012","unstructured":"Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology. 2012;50(1):1\u201312. https:\/\/doi.org\/10.4193\/Rhino12.000.","journal-title":"Rhinology"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-025-01246-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11882-025-01246-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-025-01246-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T16:03:45Z","timestamp":1767974625000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11882-025-01246-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1246"],"URL":"https:\/\/doi.org\/10.1007\/s11882-025-01246-1","relation":{},"ISSN":["1534-6315"],"issn-type":[{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"14 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"3"}}